Please wait a minute...
Reviews in Cardiovascular Medicine  2021, Vol. 22 Issue (1): 159-165     DOI: 10.31083/j.rcm.2021.01.238
Systematic Review Previous articles | Next articles
Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis
Yu-Hao Zhao1, , Lei Zhao1, , Xin-Chun Yang1, *(), Pan Wang1, *()
1Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, 100020 Beijing, P. R. China
Download:  PDF(2035KB)  ( 1113 ) Full text   ( 191 )
Export:  BibTeX | EndNote (RIS)      
Abstract:
Coronavirus Disease 2019 (COVID-19) originated in Wuhan, China in December 2019 and rapidly spread worldwide. Herein, we conducted a systematic review and meta-analysis to find the association between COVID-19 and cardiovascular complications. We conducted a systematic literature search of the PubMed and Embase databases from 01 December 2019 to 30 November 2020. We then statistically analyzed the incidence of cardiovascular complications in COVID-19 patients. We included 3044 confirmed COVID-19 cases from 12 studies. The most common cardiovascular complications in COVID-19 patients were myocardial injury (21.2%, 95% CI 12.3-30.0%) and arrhythmia (15.3%, 95% CI 8.4-22.3%), followed by heart failure (14.4%, 95% CI 5.7-23.1%) and acute coronary syndrome (1.0%, 95% CI 0.5-1.5%). The pooled incidence of heart failure, arrhythmia and myocardial injury in non-survivors were 47.8% (95% CI 41.4-54.2%), 40.3% (95% CI 1.6-78.9%) and 61.7% (95% CI 46.8-76.6%), respectively. Also, the data separately showed significantly higher incidence of heart failure and cardiac injury in non-survivors (relative risks = 5.13, 95% CI 2.46-10.7, Z = 4.36, P = 0.017) and (relative risks = 6.91, 95% CI 3.19-14.95, Z = 4.91, P = 0.009). Myocardial injury and arrhythmia were the most common complications in COVID-19 patients. Myocardial injury and heart failure were more common in patients who died, regardless of a history of cardiovascular disease. The incidence of heart failure and myocardial injury were higher in non-survivors compared to the survivors. Accordingly, in addition to basic support, cardiac reactions of patients with confirmed COVID-19 with or without underlying cardiovascular diseases should be closely monitored.
Key words:  COVID-19      Cardiovascular complications      Heart failure      Myocardial injury      Acute coronary syndrome      Arrhythmia     
Submitted:  05 November 2020      Revised:  04 January 2021      Accepted:  05 January 2021      Published:  30 March 2021     
*Corresponding Author(s):  diudiupan@163.com (Pan Wang); yangxinchun6229@163.com (Xin-Chun Yang)   
About author:  These authors contributed equally.

Cite this article: 

Yu-Hao Zhao, Lei Zhao, Xin-Chun Yang, Pan Wang. Cardiovascular complications of SARS-CoV-2 infection (COVID-19): a systematic review and meta-analysis. Reviews in Cardiovascular Medicine, 2021, 22(1): 159-165.

URL: 

https://rcm.imrpress.com/EN/10.31083/j.rcm.2021.01.238     OR     https://rcm.imrpress.com/EN/Y2021/V22/I1/159

[1] Peter A. McCullough, Raphael B. Stricker, Harvey A. Risch. Role of hydroxychloroquine in multidrug treatment of COVID-19[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 545-546.
[2] Luca Di Lullo, Antonio Bellasi, Vincenzo Barbera, Claudio Ronco. Cardionephrology and cardiorenal disease in Italy: state of the art[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 563-572.
[3] Hongbo Gan, Heng Tang, Yujie Huang, Dan Wang, Peng Pu, Zhong Zuo. The 'diamond' approach to personalized drug treatment of heart failure with reduced ejection fraction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 573-584.
[4] Ronald O. Morales, Francesc Barbosa, Nuria Farre. Peritoneal dialysis in heart failure: focus on kidney and ventricular dysfunction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 649-657.
[5] Călin Pop, Diana Țînț, Antoniu Petris. Management of antithrombotic therapy in patients with atrial fibrillation and acute coronary syndromes[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 659-675.
[6] Matteo Beltrami, Simone Bartolini, Massimo Milli, Alberto Palazzuoli. The relevance of specific heart failure outpatient programs in the COVID era: an appropriate model for every disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 677-690.
[7] Leonardo De Luca, Luca Paolucci, Annunziata Nusca, Rita Lucia Putini, Fabio Mangiacapra, Enrico Natale, Gian Paolo Ussia, Furio Colivicchi, Francesco Grigioni, Francesco Musumeci, Domenico Gabrielli. Current management and prognosis of patients with recurrent myocardial infarction[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 731-740.
[8] Sarah Fitzsimons, Robert N Doughty. Role of transthoracic echocardiogram in acute heart failure[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 741-754.
[9] César Jiménez-Méndez, Pablo Díez-Villanueva, Fernando Alfonso. Non-ST segment elevation myocardial infarction in the elderly[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 779-786.
[10] Martha Kyriakou, Anastasia Samara, Katerina Philippou, Ioanna Lakatamitou, Ekaterini Lambrinou. A qualitative meta-synthesis of patients with heart failure perceived needs[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 853-864.
[11] Yaowang Lin, Yang Chen, Jie Yuan, Xinli Pang, Huadong Liu, Shaohong Dong, Qiuling Chen. Intravenous morphine use in acute heart failure increases adverse outcomes: a meta-analysis[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 865-872.
[12] Ali Yazdanyar, Muhammad Haisum Maqsood, Jerald Pelayo, Julien Sanon, Eduardo Quintero, Kevin Bryan Lo, Roy O. Mathew, Janani Rangaswami. Clinical outcomes in patients with heart failure with and without cirrhosis: an analysis from the national inpatient sample[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 925-929.
[13] Xiao-Fei Wang, Meng-Cheng Xu, Cheng-Yu Mao, En-Zhou, Qing He, Xing-Qian Qu, Yu-Qi Fan, Chang-Qian Wang, Jun-Feng Zhang. Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1009-1017.
[14] Christian Blockhaus, Hans-Peter Waibler, Jan-Erik Gülker, Alexander Bufe, Melchior Seyfarth, Buelent Koektuerk, Dong-In Shin. Influence of excess weight and obesity on performance and outcome of pulmonary vein isolation with the cryoballoon[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1047-1052.
[15] Matthieu MILLION, Jean-Christophe LAGIER, Hervé TISSOT-DUPONT, Isabelle RAVAUX, Catherine DHIVER, Christelle TOMEI, Nadim CASSIR, Léa DELORME, Sébastien CORTAREDONA, Sophie AMRANE, Camille AUBRY, Karim BENDAMARDJI, Cyril BERENGER, Barbara DOUDIER, Sophie EDOUARD, Marie HOCQUART, Morgane MAILHE, Coralie PORCHETO, Piseth SENG, Catherine TRIQUET, Stéphanie GENTILE, Elisabeth JOUVE, Audrey GIRAUD-GATINEAU, Herve CHAUDET, Laurence CAMOIN-JAU, Philippe COLSON, Philippe GAUTRET, Pierre-Edouard FOURNIER, Baptiste MAILLE, Jean-Claude DEHARO, Paul HABERT, Jean-Yves GAUBERT, Alexis JACQUIER, Stéphane HONORE, Katell GUILLON-LORVELLEC, Yolande OBADIA, Philippe PAROLA, Philippe BROUQUI, Didier RAOULT. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients[J]. Reviews in Cardiovascular Medicine, 2021, 22(3): 1063-1072.
No Suggested Reading articles found!